Cameron Callaghan MD MPH MS (He/Him)
Gastrointestinal Cancer
Associate Consultant, Assistant Professor
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Callaghan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cameron Callaghan is a Radiation Oncologist based in Rochester, MN, specializing in gastrointestinal cancer. He completed his residency in Radiation Oncology at the University of Iowa Hospitals and Clinics in 2022 and holds an MD from Tulane University School of Medicine. Additionally, he has an MPH from Tulane School of Public Health and Tropical Medicine and an MS in Clinical Anatomy from Tulane School of Medicine. Dr. Callaghan has been employed at Mayo Clinic since 2022 and has several publications in prestigious journals focusing on radiation therapy and cancer treatment. His work has been recognized with multiple awards, including those from ASTRO and RSNA, for his contributions to radiation oncology research.
Education & Training
University of Iowa Health Care Medical CenterResidency, Radiation Oncology, 2018 - 2022
University of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola)Internship, Transitional Year, 2017 - 2018
Tulane University School of MedicineClass of 2017, MD
Tulane School of Public Health and Tropical MedicineMPH, 2013 - 2016- Tulane School of MedicineMS, Clinical Anatomy, 2013 - 2016
Certifications & Licensure
WI State Medical License 2023 - 2027
MN State Medical License 2022 - 2026
IA State Medical License 2018 - 2022
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Annual Meeting Abstract Travel Award in Biology ASTRO, 2021
- Oral Presentation ASTRO 2021 Conference ASTRO, 2021
- Holman Research Pathway in Radiation Oncology ABR, 2019-2021
Publications & Presentations
PubMed
- Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence.Cristian J Salazar-Vilches, Daniel K Ebner, Jake A Kloeber, Sonja Dragojevic, Jasvinder Singh
Cancers. 2026-02-19 - Clinical Evidence on Particle Radiation, DNA Damage Response Inhibitors, and Immunotherapy for Mismatch Repair-Proficient Rectal Cancer.Cristian J Salazar-Vilches, Daniel K Ebner, Jake A Kloeber, Sonja Dragojevic, Jasvinder Singh
Cancers. 2026-02-17 - 1 citationsPoly ADP Ribose Polymerase Inhibitors Potentiate Proton Therapy End-of-Range Effects by Accelerating Replication Forks and Promoting Transcription Conflict.Yiqun Han, Qin Zhou, Anna Dibbs, Bin Chen, Taylor M Weiskittel
International Journal of Radiation Oncology, Biology, Physics. 2026-02-01
Abstracts/Posters
- Pharmacologic Ascorbate Enhances the Therapeutic Index of ATM-Inhibitor Based Chemoradiation for Colorectal Cancer.Callaghan CM, Abukhiran I, VanRheeden R., Ali MY, Petronek MS, Mapuskar KA, Seyedin SN, Kalen AL, Rodman S, Cullen JJ, Coleman M, Goswami P, Buatti JM, Spitz DR, Allen..., Oral presentation. ASTRO 63rd Annual Conference., 10/26/2021
- Pharmacologic ascorbate enhances the therapeutic index of ATM-inhibitor based chemoradiation for colorectal cancer.Callaghan CM, Seyedin SN, Mapuskar KA, Petronek MS, VanRheeden RV, Rodman SN, Cullen JJ, Darbro BW, Spitz DR, Allen BG, Coleman MC, Goswami P, and Caster JM., ASCO 2021, 6/4/2021
- Utilizing Pharmacologic Ascorbate to Enhance the Therapeutic Index of DNA Repair Inhibitor-Based Chemoradiotherapy for Rectal Cancers.Callaghan CM, Seyedin SN, Mapuskar KA, Petronek MS, VanRheeden RV, Rodman SN, Cullen JJ, Darbro BW, Spitz DR, Allen BG, Coleman MC, Goswami P, and Caster JM., ASTRO 2020, 10/25/2020
Lectures
- Pharmacologic Ascorbate Enhances the Therapeutic Index of ATM-Inhibitor Based Chemoradiation for Colorectal CancerOral presentation ASTRO 63rd Annual Conference - 10/26/2021
- Updates in Diagnosis-specific Graded Prognostic Assessments for Brain Metastases.ISTRO 2019 - 10/26/2019
- Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniquesABS Annual Conference 2019 Miami, FL. - 3/16/2019
Grant Support
- Pharmacologic Ascorbate, DNA Repair Inhibitors, and Therapeutic Index of Radiation Therapy in Colorectal CancerRSNA2019–2020
Research History
- Holman Pathway in Radiation Oncology2019 - 2021
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
